Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients

Figure 1

(a) CTLA-4 mRNA expression levels in CLL and controls in subpopulation of CD19-positive cells; (b) BTLA mRNA expression levels in CLL and controls in subpopulation of CD19-positive cells.